Key result
Epicardial delivery of adipose-derived stromal cell sheets resulted in a significantly higher survival rate than intramyocardial cell injections (73% vs. 41%, P=0.01) in rats with chronic MI.
Why the study?
Does epicardial delivery of ADSC sheets improve survival and left ventricular remodeling compared to intramyocardial injection in a rat model of chronic myocardial infarction?
Population
82 rats with chronic myocardial infarction and simultaneous harvest of fat tissue to yield adipose-derived…
Comparison
Epicardial deposit of a trilayered autologous… vs Intramyocardial injections of either control…
Design
Preclinical, Randomized 1 month after infarction, Blindly assessed
Follow-up
2 months
Authors
Loading...
Caution against clinical use of epicardial ADSC sheets; extends preclinical delivery data but leaves human translation open.
RCT (n=82)
Assessor-blind
randomized
Does epicardial delivery of ADSC sheets improve survival and left ventricular remodeling compared to intramyocardial injection in a rat model of chronic myocardial infarction?
Absolute Event Rate: 73% vs 41%
p-value: p=0.01
Epicardial delivery of adipose-derived stromal cell sheets improves survival and preserves left ventricular geometry better than intramyocardial cell injections in a rat model of chronic myocardial infarction.
Hamdi et al. (2011) conducted an RCT in chronic myocardial infarction (n=82). Epicardial deposit of a trilayered ADSC sheet vs. Intramyocardial injections of autologous ADSC or control medium was evaluated on Survival rate (p=0.01). Epicardial delivery of adipose-derived stromal cell sheets resulted in a significantly higher survival rate than intramyocardial cell injections (73% vs. 41%, P=0.01) in rats with chronic MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: